The SNPs in the human genetic blueprint era

S. Giampaoli, G. Chillemi, F. Valeriani, D. Lazzaro, M. Borro, G. Gentile, M. Simmaco, G. Zanni, A. Berti, V. Romano Spica

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The analysis of human genetic variability can lead to the comprehension of medical issues and to the development of personalized therapeutic protocols. Single nucleotide polymorphisms, are the most common type of human genetic variation and have been associated to disease development and phenotype forecasting. The recent technologies for DNA sequencing and bioinformatic analysis are now giving the opportunity to develop new diagnostic and prevention approaches also through health promotion protocols. The genetic data management is at the same time underlining technical limitations and old ethical issues.

Original languageEnglish
Pages (from-to)475-484
Number of pages10
JournalNew Biotechnology
Volume30
Issue number5
DOIs
Publication statusPublished - Jun 25 2013

Fingerprint

Blueprints
Medical Genetics
Bioinformatics
Nucleotides
Polymorphism
Information management
Single Nucleotide Polymorphism
DNA
Health
Computational Biology
Health Promotion
DNA Sequence Analysis
Ethics
Technology
Phenotype
Therapeutics

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Biology
  • Bioengineering

Cite this

Giampaoli, S., Chillemi, G., Valeriani, F., Lazzaro, D., Borro, M., Gentile, G., ... Romano Spica, V. (2013). The SNPs in the human genetic blueprint era. New Biotechnology, 30(5), 475-484. https://doi.org/10.1016/j.nbt.2012.11.015

The SNPs in the human genetic blueprint era. / Giampaoli, S.; Chillemi, G.; Valeriani, F.; Lazzaro, D.; Borro, M.; Gentile, G.; Simmaco, M.; Zanni, G.; Berti, A.; Romano Spica, V.

In: New Biotechnology, Vol. 30, No. 5, 25.06.2013, p. 475-484.

Research output: Contribution to journalArticle

Giampaoli, S, Chillemi, G, Valeriani, F, Lazzaro, D, Borro, M, Gentile, G, Simmaco, M, Zanni, G, Berti, A & Romano Spica, V 2013, 'The SNPs in the human genetic blueprint era', New Biotechnology, vol. 30, no. 5, pp. 475-484. https://doi.org/10.1016/j.nbt.2012.11.015
Giampaoli S, Chillemi G, Valeriani F, Lazzaro D, Borro M, Gentile G et al. The SNPs in the human genetic blueprint era. New Biotechnology. 2013 Jun 25;30(5):475-484. https://doi.org/10.1016/j.nbt.2012.11.015
Giampaoli, S. ; Chillemi, G. ; Valeriani, F. ; Lazzaro, D. ; Borro, M. ; Gentile, G. ; Simmaco, M. ; Zanni, G. ; Berti, A. ; Romano Spica, V. / The SNPs in the human genetic blueprint era. In: New Biotechnology. 2013 ; Vol. 30, No. 5. pp. 475-484.
@article{4a36155f883642de8b64ce8404e3e31a,
title = "The SNPs in the human genetic blueprint era",
abstract = "The analysis of human genetic variability can lead to the comprehension of medical issues and to the development of personalized therapeutic protocols. Single nucleotide polymorphisms, are the most common type of human genetic variation and have been associated to disease development and phenotype forecasting. The recent technologies for DNA sequencing and bioinformatic analysis are now giving the opportunity to develop new diagnostic and prevention approaches also through health promotion protocols. The genetic data management is at the same time underlining technical limitations and old ethical issues.",
author = "S. Giampaoli and G. Chillemi and F. Valeriani and D. Lazzaro and M. Borro and G. Gentile and M. Simmaco and G. Zanni and A. Berti and {Romano Spica}, V.",
year = "2013",
month = "6",
day = "25",
doi = "10.1016/j.nbt.2012.11.015",
language = "English",
volume = "30",
pages = "475--484",
journal = "New Biotechnology",
issn = "1871-6784",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - The SNPs in the human genetic blueprint era

AU - Giampaoli, S.

AU - Chillemi, G.

AU - Valeriani, F.

AU - Lazzaro, D.

AU - Borro, M.

AU - Gentile, G.

AU - Simmaco, M.

AU - Zanni, G.

AU - Berti, A.

AU - Romano Spica, V.

PY - 2013/6/25

Y1 - 2013/6/25

N2 - The analysis of human genetic variability can lead to the comprehension of medical issues and to the development of personalized therapeutic protocols. Single nucleotide polymorphisms, are the most common type of human genetic variation and have been associated to disease development and phenotype forecasting. The recent technologies for DNA sequencing and bioinformatic analysis are now giving the opportunity to develop new diagnostic and prevention approaches also through health promotion protocols. The genetic data management is at the same time underlining technical limitations and old ethical issues.

AB - The analysis of human genetic variability can lead to the comprehension of medical issues and to the development of personalized therapeutic protocols. Single nucleotide polymorphisms, are the most common type of human genetic variation and have been associated to disease development and phenotype forecasting. The recent technologies for DNA sequencing and bioinformatic analysis are now giving the opportunity to develop new diagnostic and prevention approaches also through health promotion protocols. The genetic data management is at the same time underlining technical limitations and old ethical issues.

UR - http://www.scopus.com/inward/record.url?scp=84880162490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880162490&partnerID=8YFLogxK

U2 - 10.1016/j.nbt.2012.11.015

DO - 10.1016/j.nbt.2012.11.015

M3 - Article

C2 - 23183540

AN - SCOPUS:84880162490

VL - 30

SP - 475

EP - 484

JO - New Biotechnology

JF - New Biotechnology

SN - 1871-6784

IS - 5

ER -